Literature DB >> 3257748

Suppression of murine macrophage interleukin-1 release by the polysaccharide portion of Haemophilus actinomycetemcomitans lipopolysaccharide.

T Nishihara1, T Koga, S Hamada.   

Abstract

Lipopolysaccharide (LPS) was extracted from whole cells of Haemophilus actinomycetemcomitans Y4 by the hot phenol-water procedure. LPS was cleaved into its lipid A and polysaccharide moieties by hydrolysis in 1% acetic acid. The major component sugars of the polysaccharide were glucose, heptose, rhamnose, galactose, and fucose. LPS and lipid A from H. actinomycetemcomitans induced the release of interleukin-1 (IL-1) by LPS-responsive C3H/HeN murine peritoneal macrophages and cell line macrophages (P388D1 and J744.1), but not by LPS-nonresponsive C3H/HeJ peritoneal macrophages. The polysaccharide was unable to induce the release of IL-1. It suppressed the IL-1 release from LPS- and lipid A-stimulated macrophages, but not the production of cell-associated and intracellular IL-1. The addition of rhamnose, a sugar component of the polysaccharide, abrogated the inhibitory effect of the polysaccharide on IL-1 release. These results suggest the participation of a lectinlike molecule in IL-1 release.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3257748      PMCID: PMC259336          DOI: 10.1128/iai.56.3.619-625.1988

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  40 in total

1.  Prostaglandins as endogenous mediators of interleukin 1 production.

Authors:  S L Kunkel; S W Chensue; S H Phan
Journal:  J Immunol       Date:  1986-01       Impact factor: 5.422

2.  Intracellular localization of human monocyte associated interleukin 1 (IL 1) activity and release of biologically active IL 1 from monocytes by trypsin and plasmin.

Authors:  K Matsushima; M Taguchi; E J Kovacs; H A Young; J J Oppenheim
Journal:  J Immunol       Date:  1986-04-15       Impact factor: 5.422

3.  Spontaneous production of a suppressor factor by the human macrophage-like cell line U937. I. Suppression of interleukin 1, interleukin 2, and mitogen-induced blastogenesis in mouse thymocytes.

Authors:  H Fujiwara; J J Ellner
Journal:  J Immunol       Date:  1986-01       Impact factor: 5.422

4.  Bone resorbing activity of purified capsular material from Actinobacillus actinomycetemcomitans.

Authors:  M Wilson; S Kamin; W Harvey
Journal:  J Periodontal Res       Date:  1985-09       Impact factor: 4.419

5.  Prostaglandins posttranscriptionally inhibit monocyte expression of interleukin 1 activity by increasing intracellular cyclic adenosine monophosphate.

Authors:  P J Knudsen; C A Dinarello; T B Strom
Journal:  J Immunol       Date:  1986-11-15       Impact factor: 5.422

6.  Effects of immune complexes on production by human monocytes of interleukin 1 or an interleukin 1 inhibitor.

Authors:  W P Arend; F G Joslin; R J Massoni
Journal:  J Immunol       Date:  1985-06       Impact factor: 5.422

7.  Release of lymphokines after infection with Epstein Barr virus in vitro. II. A monocyte-dependent inhibitor of interleukin 1 downregulates the production of interleukin 2 and interferon-gamma in rheumatoid arthritis.

Authors:  M Lotz; C D Tsoukas; S Fong; C A Dinarello; D A Carson; J H Vaughan
Journal:  J Immunol       Date:  1986-05-15       Impact factor: 5.422

8.  Inhibition of interleukin 1 activity by a factor in submandibular glands of rats.

Authors:  A Kemp; L Mellow; E Sabbadini
Journal:  J Immunol       Date:  1986-10-01       Impact factor: 5.422

9.  Normal human neutrophils are a source of a specific interleukin 1 inhibitor.

Authors:  K Tiku; M L Tiku; S Liu; J L Skosey
Journal:  J Immunol       Date:  1986-05-15       Impact factor: 5.422

10.  Identification of a membrane-associated interleukin 1 in macrophages.

Authors:  E A Kurt-Jones; D I Beller; S B Mizel; E R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

View more
  8 in total

1.  In vitro and in vivo studies of macrophage functions in amebiasis.

Authors:  M Denis; K Chadee
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

2.  Actinobacillus actinomycetemcomitans Y4 capsular polysaccharide induces IL-1beta mRNA expression through the JNK pathway in differentiated THP-1 cells.

Authors:  T Iwata; A Mitani; Y Ishihara; S Tanaka; G Yamamoto; T Kikuchi; T Naganawa; Y Matsumura; T Suga; M Koide; T Sobue; T Suzuki; T Noguchi
Journal:  Clin Exp Immunol       Date:  2005-08       Impact factor: 4.330

3.  Immunochemical and structural characterization of a serotype-specific polysaccharide antigen from Actinobacillus actinomycetemcomitans Y4 (serotype b).

Authors:  K Amano; T Nishihara; N Shibuya; T Noguchi; T Koga
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

4.  Fibronectin as an enhancer of nonopsonic phagocytosis of Pseudomonas aeruginosa by macrophages.

Authors:  J L Kluftinger; N M Kelly; B H Jost; R E Hancock
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

5.  Production of an interleukin-1 inhibitor by cell line P388D1 murine macrophages stimulated with Haemophilus actinomycetemcomitans lipopolysaccharide.

Authors:  T Nishihara; T Koga; S Hamada
Journal:  Infect Immun       Date:  1988-11       Impact factor: 3.441

6.  Mouse interleukin-1 receptor antagonist induced by Actinobacillus actinomycetemcomitans lipopolysaccharide blocks the effects of interleukin-1 on bone resorption and osteoclast-like cell formation.

Authors:  T Nishihara; Y Ohsaki; N Ueda; N Saito; G R Mundy
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

7.  Murine macrophage interleukin-1 release by capsularlike serotype-specific polysaccharide antigens of Actinobacillus actinomycetemcomitans.

Authors:  T Takahashi; T Nishihara; Y Ishihara; K Amano; N Shibuya; I Moro; T Koga
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

8.  Chemical differences in lipopolysaccharides from Actinobacillus (Haemophilus) actinomycetemcomitans and Haemophilus aphrophilus: clues to differences in periodontopathogenic potential and taxonomic distinction.

Authors:  I Brondz; I Olsen
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.